Misplaced Pages

Ilepcimide: Difference between revisions

Article snapshot taken from[REDACTED] with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

Browse history interactively ← Previous edit Next edit →Content deleted Content addedVisual WikitextInline

Revision as of 00:52, 1 July 2011 editCheMoBot (talk \| contribs)Bots141,565 edits Updating {{drugbox}} (changes to verified fields - updated 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEMBL_Ref', 'KEGG_Ref') per Chem/Drugbox validation (report [[Misplaced Pages talk:Wi← Previous edit		Revision as of 18:12, 11 August 2011 edit undoCheMoBot (talk \| contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'ChemSpiderID_Ref', 'DrugBank_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'DrugBank_Ref', 'ChEBI_Ref') per [[Misplaced Pages:WikiProject Chemicals/Next edit →
Line 1:		Line 1:
	{{drugbox		{{drugbox
		⚫	\| UNII_Ref = {{fdacite\|correct\|FDA}}
	\| Verifiedfields = changed
⚫	\| UNII_Ref = {{fdacite\|~~changed~~\|FDA}}
	\| UNII = 5ML58O200F		\| UNII = 5ML58O200F
	\| verifiedrevid = ~~376098878~~		\| verifiedrevid = 437147957
	\| IUPAC_name = (E)-3-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylprop-2-en-1-one		\| IUPAC_name = (E)-3-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylprop-2-en-1-one
	\| image = Ilepcimide.png		\| image = Ilepcimide.png

Revision as of 18:12, 11 August 2011

Pharmaceutical compound

Ilepcimide
Clinical data

ATC code	none
Identifiers
IUPAC name (E)-3-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylprop-2-en-1-one
CAS Number	23434-86-8
PubChem CID	641115
UNII	5ML58O200F
Chemical and physical data
Formula	C₁₅H₁₇NO₃
Molar mass	259.300 g/mol g·mol
3D model (JSmol)	Interactive image
SMILES C1CCN(CC1)C(=O)/C=C/C2=CC3=C(C=C2)OCO3
(verify)

Ilepcimide (Antiepilepserine) is a piperidine anticonvulsant used in China.

References

v
t
e

Anticonvulsants (N03)

GABA_AR PAMs	Barbiturates: Barbexaclone Metharbital Methylphenobarbital Pentobarbital Phenobarbital Primidone; Carbamates: Cenobamate Felbamate; Benzodiazepines: Clobazam Clonazepam Clorazepate Diazepam Lorazepam Midazolam Nimetazepam Nitrazepam Temazepam; Others: Bromide (potassium bromide, sodium bromide) Imepitoin Paraldehyde Stiripentol
GABA-T inhibitors	Fatty acids (and related): Valproate Valpromide Valproate pivoxil Vigabatrin
Others	GABAR agonists: Progabide; GAT-1 inhibitors: Tiagabine

Channel
modulators

Sodium blockers	Hydantoins: Ethotoin Fosphenytoin Mephenytoin Phenytoin; Ureides: Acetylpheneturide Chlorphenacemide Phenacemide Pheneturide; Fatty acids: Valproate Valpromide Valproate pivoxil; Carboxamides: Carbamazepine Eslicarbazepine acetate Oxcarbazepine; Others: Lacosamide Lamotrigine Rufinamide Topiramate Zonisamide
Calcium blockers	Oxazolidinediones: Ethadione Paramethadione Trimethadione; Succinimides: Ethosuximide Mesuximide Phensuximide; Gabapentinoids: Gabapentin Pregabalin; Others: Imepitoin Lamotrigine Topiramate Zonisamide
Potassium openers	Retigabine

Others

CA inhibitors	Sulfonamides: Acetazolamide Ethoxzolamide Sultiame Topiramate Zonisamide
Others	Albutoin Beclamide Brivaracetam Cannabidiol Carisbamate Etiracetam Fenfluramine Ganaxolone Levetiracetam Perampanel

WHO-EM
Withdrawn from market
Clinical trials:
- Phase III
- Never to phase III

This anticonvulsant-related article is a stub. You can help Misplaced Pages by expanding it.

v
t
e

Ilepcimide: Difference between revisions Add topic